Stay updated on Intranasal Esketamine in Treatment-resistant Depression Clinical Trial
Sign up to get notified when there's something new on the Intranasal Esketamine in Treatment-resistant Depression Clinical Trial page.

Latest updates to the Intranasal Esketamine in Treatment-resistant Depression Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange Detected- Added a government funding lapse notice and operating-status guidance, plus a version bump to v3.2.0. - Removed the old version reference v3.1.0.SummaryDifference10%
- Check15 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0, indicating a newer release.SummaryDifference0.2%
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2 and the 'Back to Top' element was removed.SummaryDifference0.6%
- Check37 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.SummaryDifference0.6%
- Check44 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, as well as multiple entries related to study statuses and contacts. However, several location-related terms and details have been removed.SummaryDifference32%
- Check58 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.3%
Stay in the know with updates to Intranasal Esketamine in Treatment-resistant Depression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intranasal Esketamine in Treatment-resistant Depression Clinical Trial page.